2-(morpholin-4-yl)benzo(h)chromen-4-one,
NU 7026,
NU-7026,
NU7026,
154447-35-5,
NU7026,
NU 7026,
DNA-PK Inhibitor II,
2-(Morpholin-4-yl)-benzo[h]chromen-4-one,
NU-7026,
LY293646,
2-morpholino-4H-benzo[h]chromen-4-one,
LY-293646,
2-(4-morpholinyl)-4H-naphtho[1,2-b]pyran-4-one,
2-(4-Morpholinyl)-4H-naphthol[1,2-b]pyran-4-one,
CHEMBL104468,
MFCD06798345,
AK186905,
DNA-Dependent Protein Kinase Inhibitor II,
2-morpholin-4-ylbenzo[h]chromen-4-one,
SCHEMBL610237,
GTPL5959,
ZINC9230,
CHEBI:92165,
CTK0E7833,
KS-00000XHI,
AOB2835,
DTXSID10432010,
HMS3229C11,
HMS3675M22,
BCP04736,
EX-A1100,
BDBM50098126,
HSCI1_000223,
IN1364,
s2893,
AKOS015994580,
API0003646,
BCP9001001,
CCG-206743,
CS-1532,
ES-0046,
RL01985,
NCGC00165840-01,
2-Morpholin-4-yl-benzo[h]chromen-4-one,
BC283274,
HY-15719,
SC-95157,
2-(morpholin-4-yl)benzo[h]chromen-4-one,
BCP0726000029,
NU7026, >=98% (HPLC), solid,
AB0081566,
RT-012394,
FT-0701904,
Y1895,
EC-000.2421,
2-(morpholin-4-yl)-4H-benzo[h]chromen-4-one,
W-5341,
CU-00000000014-1,
J-506082,
BRD-K09537769-001-01-6,
BRD-K09537769-001-02-4,
2-(4-Morpholinyl)-4H-naphtho[1,2-b]pyran-4-one, NU7026,
D03TVF,
D0W1ST,
cc-674,
C17H15NO3,
CID9860529,
DA-43999,
2-(morpholin-4-yl)benzo(h)chromen-4-one,
A8649,
A12752,
C479235,
4H-Naphtho[1,2-b]pyran-4-one, 2-(4-morpholinyl)-,
Ethyl 1-[(1H-benzimidazol-2(3H)one-5-yl)sulfonyl]-1H-pyrrole-2-carboxylate,